News

Structure-guided discovery of potent and dual-acting human parainfluenza virus haemagglutinin–neuraminidase inhibitors. Nature Communications, 2014; 5: 5268 DOI: 10.1038/ncomms6268 ...
A new study shows that while RSV mostly affects younger kids, the often-overlooked human metapneumovirus also hospitalizes ...
Home > Press release: Just breathe: fighting viral respiratory ... A research team at MHH wants to use the CRISPR-Cas13 system to cut up viral RNA and thus stop the pathogens from multiplying. The ...
Human parainfluenza viruses are a major cause of respiratory infections that particularly affect young children and immunocompromised individuals. These viruses present a significant global health ...
Sendai behaves in mice in very much the same way that human parainfluenza virus behaves in people, making it an excellent model of the kinds of infections that could lead to chronic lung disease.
A dual drug regimen synergistically blocks human parainfluenza virus infection. Scientific Reports, 2016; 6: 24138 DOI: 10.1038/srep24138 ...
Download Customised PDF One step closer to identifying a treatment for the dreaded Human Parainfluenza virus has been taken by the researchers at Griffith University's Institute for Glycomics.
The human parainfluenza virus (HPIV) is an enveloped, negative-sense, single-stranded RNA virus that belongs to the family of Paramyxoviridae.
The immunized animals showed complete protection from challenge infection with prototype live virus but failed to demonstrate a significant level of protection against either human parainfluenza type ...